BETAAccess all features while we're in beta! Some features may become paid later.Send feedback →
vpside

COYA

Coya Therapeutics, Inc.
Nasdaq · Pharmaceutical preparations (SIC 2834) · FY ends 31 Dec

Revenue, quarterly

$243745+49.0% year on year
$8M$5M$3M$0
Q1 ’23Q4 ’23Q4 ’24Q3 ’25Q2 ’26
Company filings · 10-Q filed 11 Aug 2026 · Q4 = FY − 9Mvpside.com

Gross margin, trailing twelve months

—
Not reported in this company’s filings
Company filingsvpside.com

Cash and cash equivalents, quarter-end

$43M+45.1% year on year
$60M$40M$20M$0
Q1 ’23Q4 ’23Q4 ’24Q3 ’25Q2 ’26
Company filings · 10-Q filed 11 Aug 2026 · balance sheet, period-endvpside.com

Free cash flow, trailing twelve months

—
Not reported in this company’s filings
Company filingsvpside.com
Chart 05 is empty
Chart 06 is empty